Quadria Capital Investment Management, an Asia-focused healthcare private equity company, is reportedly planning to invest up to $1bn in India's healthcare sector over the next two-and-a-half years.  

The company, which currently manages approximately $3.4bn in global healthcare assets, is looking to acquire minority stakes in healthcare companies, Bloomberg reported.  

This move is anticipated to potentially double Quadria Capital’s current investment in the country. 

According to Bloomberg, Quadria Capital Investment Management partner Sunil Thakur, during an interview in Mumbai, India, revealed that the company has already deployed roughly half of each of its prior funds in India, with $1bn of assets under management in the country. 

Thakur said: “We will evolve into more buyouts eventually, but currently we like backing entrepreneurs and working closely with them to help grow the companies.” 

The private equity company is in the process of raising money for its third fund, having secured $500m last year, following the closure of its second fund in 2020 at $595m. 

Thakur stated that the investment strategy of Quadria Capital involves injecting between $75m and $200m into healthcare domain, mainly by acquiring minority stakes ranging from 15% to 45%.  

He further informed that the company’s investment focus spans five key themes – local manufacturing, consumer healthcare, consolidation, products and services outsourcing, as well as digitalisation. 

Within these areas, Quadria Capital is particularly optimistic about the prospects of single specialty clinics, nutraceuticals, diagnostic companies, and contract manufacturing, Thakur added. 

Quadria Capital noted that while ambulatory-care models and rehabilitation clinics are common in developed markets, they are yet to establish a strong presence in India, presenting an opportunity for growth in single specialty companies. 

The company’s recent investments include Maxvision Eye Hospitals and NephroPlus Dialysis.